Source: International Congress 2017 – Primary Care programme 2017 (part I)
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
António Jaime Correia De Sousa (PORTO, Portugal). Transforming care for chronic conditions . International Congress 2017 – Primary Care programme 2017 (part I)

Member's Comments

No comment yet.

Related content which might interest you: Transforming respiratory care: why now is the time to act Source: Virtual Congress 2021 – Transforming respiratory care: why now is the time to act Year: 2021 Transforming growth factor-beta1 (TGF-beta1) gene polymorphism in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 190s Year: 2006 Transforming growth factor beta-1 gene polymorphisms and course of asthma Source: Annual Congress 2011 - New insights in the incidence, variation and risk factors of asthma Year: 2011 Transforming growth factor beta 1 (TGF-ß1) level as a marker of COPD severity Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 Transforming growth factor-beta 1 (TGF-beta1) gene polymorphism in coincidence with some other host and environmental factors is associated with irreversible bronchoconstriction in asthmatics Source: Eur Respir J 2006; 28: Suppl. 50, 191s Year: 2006 Are we really transforming asthma and COPD management with biologics? Source: International Congress 2018 – State of the art session: Airways disease Year: 2018 Transforming growth factor-? gene polymorphisms in different phenotypes of sarcoidosis Source: Eur Respir J 2011; 37: 169-175 Year: 2011 Influence of tobacco-smoking on serum level of transforming growth factor (TGF) beta 1 in COPD patients Source: International Congress 2017 – COPD biomarkers Year: 2017 Transforming growth factor β in induced sputum and whole blood in cystic fibrosis Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Transforming growth factor-β1 gene polymorphism and susceptibility to idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 267s Year: 2005 Transforming growth factor-ß1 and Matrix Metalloproteinase-9 as factors of airway remodeling among asthmatic patients Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018 Cytokines in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 50S-59S Year: 2001 Integrating palliative care into the care of the acute or critical care setting Source: School Course 13 Year: 2013 Exploring the provision of supportive care for patients with severe, life-limiting COPD in Malaysia Source: Virtual Congress 2020 – Organising respiratory disease management in primary care Year: 2020 The contribution of transforming growth factor-β and epidermal growth factor signalling to airway remodelling in chronic asthma Source: Eur Respir J 2006; 27: 208-229 Year: 2006 Transforming growth factor beta (TGFβ)-2 and -3 gene polymorphisms in different phenotypes of sarcoidosis Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 Amplified virus infection in a transforming growth factor-beta (TGFB) transgenic mouse model of inflammatory lung disease Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 Transforming growth factor beta induces Beclin-1 in pulmonary arterial endothelial cells Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Upregulation of basic fibroblast growth factor in smokers with chronic bronchitis Source: Eur Respir J 2006; 27: 957-963 Year: 2006 Platelet-derived growth factor levels in sputum of patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 423s Year: 2002